PRAX Praxis Precision Medicines, Inc.
Stock Price & Overview

$50.540.24 (+0.48%)4:00 PM 07/11/25
NASDAQ | $USD | Post-Market: $53.91 +3.37 (+6.67%) 6:49 PM

PRAX Stock Price

EPS
PE
Div Rate
Yield
Short Interest
Market Cap
Volume
Prev. Close

Quant Ranking

Latest Headlines

Ratings Summary

People Also Follow

Similar to PRAX

ETFs Holding PRAX

PRAX Company Profile

Praxis Precision Medicines, Inc. logo
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance. The company’s platforms include cerebrum, a small molecule platform for CNS small molecule therapies to develop orally available precision therapies; and solidus to discover and develop antisense oligonucleotide. It also develops Ulixacaltamide, a small molecule inhibitor of T-type calcium channels that is in Phase 3 clinical trial for the treatment of essential tremor; Vormatrigine, a small molecule targeting the hyperexcitable state of sodium-channels in the brain to treat focal onset epilepsy; Relutrigine for the treatment of developmental and epileptic encephalopathies; PRAX-020 to treat KCNT1; and PRAX-050. In addition, the company develops Elsunersen, a clinical-stage ASO designed to regulate NaV1.2 expression for the treatment of SCN2A-DEE; PRAX-080 that targets PCDH19-related developmental epilepsy; PRAX-090 for targeting SYNGAP1 loss-of-function; and PRAX-100 that targets SCN2A LoF mutations. It has a license agreement with RogCon Inc.; and research collaboration and license agreement with Ionis Pharmaceuticals, Inc. Praxis Precision Medicines, Inc. was incorporated in 2015 and is based in Boston, Massachusetts.
Employees
116
Founded
2015
Address
  • 99 High Street
  • 30th Floor
  • Boston, MA, 02110
  • United States
Phone Number
617 300 8460

PRAX Revenue

PRAX Earnings Per Share

Earnings Estimates

Earnings Revisions

Valuation

Growth

Profitability

Momentum

Capital Structure

Dividends

PRAX does not currently pay a dividend.

PRAX Ownership

PRAX Peers

Risk

Technicals

PRAX Transcripts

Investor Presentations

PRAX SEC Filings

PRAX Income Statement

PRAX Balance Sheet

PRAX Cash Flow Statement

PRAX Long Term Solvency

Praxis Precision Medicines, Inc. (PRAX) Frequently Asked Questions